Important patient information – Mounjaro (tirzepatide)

From 23 June 2025, Mounjaro (tirzepatide), a new weight loss medication, will be available to some patients through GP practices. This medication is part of a carefully managed NHS rollout and is not available to everyone.

Key information for patients

• Strict eligibility criteria applies. The NHS has set clear guidelines on who can be prescribed Mounjaro, based on medical need and national policy.
• Your GP practice will contact you directly if you meet the criteria and are eligible for this treatment.
• If you do not hear from your GP practice, it means you do not meet the eligibility criteria.

Eligibility criteria

To get Mounjaro, you must:

• Have a Body Mass Index (BMI) of 40 or more, and
• Have at least four of the following health problems:
  • High blood pressure
  • High cholesterol or fat levels in your blood
  • Sleep apnoea (trouble breathing while sleeping)
  • Heart disease
  • Type 2 diabetes

You can find more details in the official NHS guidance.

Explore other NHS resources

We understand that many people are keen to explore weight loss options. While Mounjaro may not be suitable for everyone, there is a range of support available to help you manage your health and wellbeing.

• NHS weight loss plan: a free, 12-week plan that helps you develop healthier eating habits, be more active, and start losing weight.
• NHS food scanner app: an easy way to check food labels and find healthier swaps when shopping.
• Couch to 5k: a simple, free running plan for absolute beginners. It’s perfect if you want to get moving but don’t know where to start.
• NHS Active 10 walking tracker: a free app that encourages you to do at least 10 minutes of brisk walking a day.

To learn more about Mounjaro and weight loss medication in general, please visit the North East and North Cumbria NHS website.